Thomas Savage

7PUBLICATIONS
54CO-AUTHORS
BiomaterialsHealth counsellingCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2026
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models.

|Mar 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3.

Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang

|Oct 18, 2024
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanisms.

Fangda Li, Zaofeng Yang, Thomas M Savage

|Apr 26, 2024
Treg-tissue cell interactions in repair and regeneration.

Lucas F Loffredo, Thomas M Savage, Olivia R Ringham

|Oct 12, 2023
Probiotic-guided CAR-T cells for solid tumor targeting.

Rosa L Vincent, Candice R Gurbatri, Fangda Li

|Mar 08, 2023
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity.

Thomas M Savage, Rosa L Vincent, Sarah S Rae

Pageof 2

Frequent Collaborators

6 joint publications

Nicholas Arpaia

4 joint publications

Kenia de Los Santos-Alexis

4 joint publications

Rosa L Vincent

4 joint publications

Tal Danino